Comparison Between the Efficacy of Ultrasound-guided Erector Spinae Plane Block and Conventional Treatment for Pain Management in Patients With Post-herpetic Neuralgia
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: erector spinae plane block.
- Who it may be relevant to
- Registry conditions: Post-Herpetic Neuralgia. Basic parameters: 20 years — 70 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The present study aims to evaluate the efficacy of ultrasound-guided erector spinae plane block with steroids to relieve pain in cases of post-herpetic neuralgia, patient satisfaction, and record any complications post-injection.
Detailed description
The current study will be conducted as a single-blinded prospective randomized controlled study to evaluate the efficacy of ultrasound-guided erector spinae plane block with steroids to relieve pain in cases of post-herpetic neuralgia.
All patients will be evaluated by:
* Full history taking: including age, sex, presence of co-morbid conditions as well as the presenting complaint. * Clinical examination and routine lab investigations that include:
* Complete blood count (CBC). * Fasting blood glucose (FBG). * Coagulation profile (bleeding time, prothrombin time, prothrombin activity, international normalized ratio).
Measurements:
Patients will be followed up at 24 hours, 1 week, and 6 weeks after injection.
The following measurements will be recorded:
1. Pain will be assessed pre- and post-injection using VAS score at 24 hours, 1 week, and 6 weeks post-injection. 2. Need for analgesic intake post-injection will be assessed at the follow-up periods. 3. Patient satisfaction using the SAPS score. 4. Complications post-injection as pain, irritation or infection will be assessed.
Interventions
- Procedure erector spinae plane block
erector spinae plane block with steroids
Primary outcome measures
- Evaluate the efficacy of ultrasound-guided erector spinae plane block with steroids to relieve pain in cases of post-herpetic neuralgia [Time frame: 6 weeks]
Secondary outcome measures (2)
- Patient satisfaction [Time frame: 6 weeks]
- Complications [Time frame: 6 weeks]
Eligibility criteria
Inclusion criteria
- Patients with post-herpetic neuralgia not responding to medical treatment.
Exclusion criteria
\- 1- Patient refusal 2- Age less than 20 years or older than 70 years. 3- Systemic Infection. 4-Patients with dementia or other diseases that could have impaired their memory or cognitive function.
5- Immunocompromised patients, severe osteoporosis, and uncontrolled diabetes mellitus.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Double blind
- Primary purpose
- Treatment
Study locations
Egypt · 1 center
- Alexandria University — Alexandria
Identifiers
NCT: NCT07256145 · 0307429